Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

1(10%)

Results Posted

100%(4 trials)

Terminated

2(20%)

Phase Distribution

Ph phase_2

10%

Ph phase_4

30%

Ph not_applicable

30%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

2(22.2%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 4Post-market surveillance

3(33.3%)

N/ANon-phased studies

3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(2)

Other(3)

Detailed Status

Completed4

unknown3

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (22.2%)

Phase 21 (11.1%)

Phase 43 (33.3%)

N/A3 (33.3%)

Trials by Status

completed440%

terminated220%

unknown330%

recruiting110%

Recent Activity

1 active trials

Showing 5 of 10

recruitingphase_2

Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)

NCT01753882

unknownphase_1

Serotonergic Modulation of Motor Function in Subacute and Chronic SCI

NCT01788969

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT05519683Phase 2

Home Transcutaneous Electrical Acustimulation (TEA)

Recruiting

NCT02516332Not Applicable

Exercise and Pharmacotherapy for Anxiety in Cardiac Patients

Completed

NCT00643162Not Applicable

Combination Lexapro and Massage for Treatment of Depression in Older Adults

Terminated

NCT01753882Phase 1

Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)

Unknown

NCT01788969Phase 1

Serotonergic Modulation of Motor Function in Subacute and Chronic SCI

Unknown

NCT00749125Not Applicable

fMRI Studies of Emotional Brain Circuitry in People With Major Depression

Completed

NCT01244724Phase 4

Lexapro for Major Depression in Patients With Epilepsy

Terminated

NCT00223288

Impact of Caregiver Depression on Asthma in the Child

Completed

NCT00767871Phase 4

Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder

Completed

NCT01078870Phase 4

Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype

Unknown

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10